To our community: Due to circumstances surrounding COVID-19, Clinical Research IO had to make the difficult decision to discontinue funding for Caretalk. We've decided to leave the website up as a resource for the community. Thank you so much to everyone who made this possible, and please enjoy!

Combination (Cholinesterase Inhibitors & NMDA Agonists)

Temporarily relieves the behavioral effects of weakening brain connections.

Drug simultaneously acts through mechanisms of memantine and donepezil. Memantine prevents glutamate (a molecule in the brain that sends messages between brain cells) from interacting with NMDA receptors in the brain, which has been found to alleviate side effects of Alzheimer's. Donepezil inhibits clearance of acetylcholine (a molecule that sends signals from one brain cell to another), which helps to preserve brain connections and normal activity.

Namzaric is for moderate to severe stages of Alzheimer's.

Treatments With This Medication Class

Combination (Cholinesterase Inhibitors & NMDA Agonists)

Compare Name Manufacturer
How To Take It
Cost Follow
Namzaric (Memantine hydrochloride XR and Donepezil hydrochloride) Forest Laboratories, Inc. By Mouth (Tablet) Combination (Cholinesterase Inhibitors & NMDA Agonists) $604.56

Related Articles from Researchers & Patients